|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Hematuria | |||||
| Hematospermia | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Hemospermia | |||||
| 3 | More general conditions related to this trial | ||||
| Genital Diseases, Male | |||||
| Hemorrhage | |||||
| Pathologic Processes | |||||
| Urination Disorders | |||||
| Urologic Diseases | |||||
| 4 | Interventions listed in this trial | ||||
| Finasteride | |||||
| 5 | More general drug interventions related to this trial | ||||
| Enzyme Inhibitors | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| 6 | Sponsors listed in this trial | ||||
| University of British Columbia | |||||
| Health, Canada | |||||
| Merck Frosst Canada Ltd. | |||||